US2554736A
(en)
|
|
1951-05-29 |
|
Tertiary aminoalkyl-iminodibenzyls |
US3282942A
(en)
|
|
1966-11-01 |
|
Substituted cycloalkanoindoles |
US532248A
(en)
|
|
1895-01-08 |
|
powell |
US2868818A
(en)
|
1953-12-15 |
1959-01-13 |
Merck & Co Inc |
Alpha methyl phenylalanines
|
US3046283A
(en)
|
1957-08-19 |
1962-07-24 |
Merck & Co Inc |
10-(omega-aminoalkylidene)-thioxanthenes
|
NL110232C
(fr)
|
1958-12-06 |
|
|
|
US3409640A
(en)
|
1959-07-22 |
1968-11-05 |
Schering Corp |
5-(3'-dimethylamino-2'-methyl-propyl)dibenzocycloheptenes
|
NL256051A
(fr)
|
1959-09-22 |
|
|
|
NL274885A
(fr)
|
1960-09-16 |
|
|
|
US3454554A
(en)
|
1960-10-14 |
1969-07-08 |
Colgate Palmolive Co |
Aminoalkyliminodibenzyl compounds
|
NL279409A
(fr)
|
1961-06-08 |
|
|
|
US3158648A
(en)
|
1962-04-09 |
1964-11-24 |
Merck & Co Inc |
Direct resolution of alpha-methyl-3, 4-dihydroxyphenylalanine
|
US3202660A
(en)
|
1961-10-09 |
1965-08-24 |
Boehringer Sohn Ingelheim |
Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes
|
BE674185A
(fr)
|
1961-10-10 |
|
|
|
CH426833A
(de)
|
1962-03-27 |
1966-12-31 |
Dumex Ltd As |
Verfahren zur Herstellung des N-Oxyds des N-(3-Dimethylamino-propyl)-iminodibenzyls oder seiner Salze
|
US3205264A
(en)
|
1962-06-15 |
1965-09-07 |
Merck & Co Inc |
Process for the preparation of 10, 11-dihydro-5-(gamma-methyl-and dimethyl-amino propylidene)-5h-dibenzo[a, d] cycloheptene
|
US3244748A
(en)
|
1962-07-03 |
1966-04-05 |
Merck & Co Inc |
5h-dibenzo [a, d] cycloheptenes
|
US3271451A
(en)
|
1962-07-03 |
1966-09-06 |
Merck & Co Inc |
Process for preparing 5-(3-methylaminopropyl)-5h-dibenzo [a, d] cycloheptenes
|
US3922305A
(en)
|
1962-08-09 |
1975-11-25 |
Merck & Co Inc |
Chemical compounds
|
NL297097A
(fr)
|
1962-08-31 |
|
|
|
US3310553A
(en)
|
1962-09-25 |
1967-03-21 |
Pfizer & Co C |
Alkylated thioxathenesulfonamides
|
GB991651A
(en)
|
1963-02-20 |
1965-05-12 |
Dumex Ltd As |
Dibenzocycloheptadiene derivatives
|
US3389139A
(en)
|
1963-06-14 |
1968-06-18 |
Wander Ag Dr A |
6-homopiperazino and piperazinomorphanthridines
|
FR88751E
(fr)
|
1963-07-09 |
1967-06-07 |
|
|
US3981917A
(en)
|
1963-07-25 |
1976-09-21 |
Merck & Co., Inc. |
Chemical compounds
|
US3978121A
(en)
|
1963-07-25 |
1976-08-31 |
Merck & Co., Inc. |
5H Dibenzo[a,d]cycloheptene derivatives
|
US3963778A
(en)
|
1965-11-10 |
1976-06-15 |
Bayer Aktiengesellschaft |
Basic oximes and their preparation
|
US3505321A
(en)
|
1965-11-24 |
1970-04-07 |
Bayer Ag |
Basically substituted oximes of 5h-dibenzo-(a,d)10,11-dihydro-cycloheptenylidene and their preparation
|
NL129434C
(fr)
|
1966-03-12 |
|
|
|
GB1192812A
(en)
|
1966-05-20 |
1970-05-20 |
American Cyanamid Co |
2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts
|
FR1532301A
(fr)
|
1967-01-18 |
1968-07-12 |
Rhone Poulenc Sa |
Nouveaux dérivés de la dibenzazépine et leur préparation
|
US3539573A
(en)
|
1967-03-22 |
1970-11-10 |
Jean Schmutz |
11-basic substituted dibenzodiazepines and dibenzothiazepines
|
GB1177525A
(en)
|
1967-04-13 |
1970-01-14 |
Leo Ab |
New Heterocyclic Aminoketones of Therapeutic Interest
|
CH479559A
(de)
|
1967-09-26 |
1969-10-15 |
Wander Ag Dr A |
Verfahren zur Herstellung von Acylguanidinen
|
US3892777A
(en)
|
1968-05-01 |
1975-07-01 |
Hoffmann La Roche |
Substituted benzylethylenedicarbamates
|
US3758528A
(en)
|
1970-03-13 |
1973-09-11 |
Science Union & Cie |
Tricyclic compounds
|
US4017542A
(en)
|
1971-02-23 |
1977-04-12 |
Ciba-Geigy Corporation |
9-(2-Hydroxy-3-amino-propyl)-9,10-dihydro-9,10-ethano-anthracenes and salts thereof
|
US4045580A
(en)
|
1971-02-23 |
1977-08-30 |
Ciba-Geigy Corporation |
Pharmaceutical preparation using 9-(2-hydroxy-3-amino-propyl)-9,10-dihydro-9,10-ethano-anthracenes as antidepressants
|
US4250094A
(en)
|
1971-04-28 |
1981-02-10 |
The Upjohn Company |
1-(Aminoalkyl) substituted-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
|
US4029792A
(en)
|
1972-02-29 |
1977-06-14 |
Pfizer Inc. |
(2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents
|
BE795970A
(fr)
|
1972-02-29 |
1973-08-27 |
Pfizer |
Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
|
JPS5229318B2
(fr)
|
1972-03-30 |
1977-08-01 |
|
|
CH570401A5
(fr)
|
1972-05-09 |
1975-12-15 |
Wander Ag Dr A |
|
GB1422263A
(en)
|
1973-01-30 |
1976-01-21 |
Ferrosan As |
4-phenyl-piperidine compounds
|
US4020096A
(en)
|
1974-02-01 |
1977-04-26 |
Merck & Co., Inc. |
10,11,Dihydro-N-alkoxycarbonyl-10,10,11,11-tetrafluoro-5H-dibenzo[a,d]cycloheptene-5-methylamines
|
US4193926A
(en)
|
1974-03-20 |
1980-03-18 |
Schering Aktiengesellschaft |
4-(Polyalkoxy phenyl)-2-pyrrolidones
|
US4097483A
(en)
|
1974-11-01 |
1978-06-27 |
Kyorin Pharmaceutical Co., Ltd. |
Pyrazolo 1,5-a!pyridines
|
US4017621A
(en)
|
1974-12-09 |
1977-04-12 |
Sumitomo Chemical Company, Limited |
2-Morpholinyl tricyclic dibenzazepine compounds
|
US3956296A
(en)
|
1974-12-11 |
1976-05-11 |
A. H. Robins Company, Incorporated |
1-Substituted-4-benzylpiperidines
|
US4358620A
(en)
|
1974-12-13 |
1982-11-09 |
Sumitomo Chemical Company, Limited |
9-Formyl-9,10-dihydro-9,10-methanoanthracene
|
GB1508669A
(en)
|
1974-12-13 |
1978-04-26 |
Sumitomo Chemical Co |
Methanoanthracene derivative and a process for the preparation thereof
|
NL189199C
(nl)
|
1975-04-05 |
1993-02-01 |
Akzo Nv |
Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
|
US4048223A
(en)
|
1975-04-11 |
1977-09-13 |
Merck & Co., Inc. |
3-Dimethylsulfamoyl-5-[amino(alkyl or alkylidene)]-5H-dibenzo [a,d]cycloheptenes
|
US4014335A
(en)
|
1975-04-21 |
1977-03-29 |
Alza Corporation |
Ocular drug delivery device
|
JPS527972A
(en)
|
1975-07-07 |
1977-01-21 |
Sumitomo Chem Co Ltd |
Process for preparing novel morpholine derivatives
|
FR2319333A1
(fr)
|
1975-07-28 |
1977-02-25 |
Roussel Uclaf |
Nouveaux derives du 7-amino 6,7-dihydro/5h/ benzocycloheptene et leurs sels, procede de preparation et application a titre de medicaments de ces produits
|
US4128641A
(en)
|
1975-07-31 |
1978-12-05 |
Hzi Research Center Inc. |
Tetracyclic psychotropic drug
|
GB1531278A
(en)
|
1975-12-15 |
1978-11-08 |
Shionogi & Co |
9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof
|
US4088647A
(en)
|
1976-02-04 |
1978-05-09 |
Glushkov Robert Georgievich |
Pyrazino (1,2,3-ab)-β-carboline derivatives and salts thereof and method of preparing same
|
NL7610942A
(nl)
|
1976-10-02 |
1978-04-04 |
Akzo Nv |
Werkwijze voor het bereiden van 1,4-diazepine derivaten.
|
US4160452A
(en)
|
1977-04-07 |
1979-07-10 |
Alza Corporation |
Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
IE46852B1
(en)
|
1977-06-10 |
1983-10-05 |
Otsuka Pharma Co Ltd |
Novel carbostyril derivatives
|
DE2727481A1
(de)
|
1977-06-18 |
1979-01-11 |
Basf Ag |
Dihydropyridazone und dihydropyridazone enthaltende therapeutische mittel
|
CA1114379A
(fr)
|
1977-11-03 |
1981-12-15 |
Pfizer Corporation |
Piperidino-phtalazines
|
SE445174B
(sv)
|
1978-03-07 |
1986-06-09 |
Sandoz Ag |
Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
|
NL171194C
(nl)
|
1978-05-23 |
1983-02-16 |
Giesen Metaalgieterij |
Warmwater-ketel, bijvoorbeeld een centrale verwarmingsketel.
|
US4287175A
(en)
|
1978-06-22 |
1981-09-01 |
Merck & Co., Inc. |
Contact lens wetting agents
|
DE2837161A1
(de)
|
1978-08-25 |
1980-03-06 |
Thomae Gmbh Dr K |
Neue benzimidazole und deren verwendung
|
NL7809726A
(nl)
|
1978-09-26 |
1980-03-28 |
Akzo Nv |
Nieuwe tetracyclische verbindingen.
|
JPS6056143B2
(ja)
|
1979-08-02 |
1985-12-09 |
山之内製薬株式会社 |
アミジン誘導体ならびにその製造法
|
PH16099A
(en)
|
1979-03-06 |
1983-06-24 |
Yamanouchi Pharma Co Ltd |
Guanidinothiazole compounds,process for preparing them and medical composition containing them
|
US4254129A
(en)
|
1979-04-10 |
1981-03-03 |
Richardson-Merrell Inc. |
Piperidine derivatives
|
US4285957A
(en)
|
1979-04-10 |
1981-08-25 |
Richardson-Merrell Inc. |
1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
|
US4285958A
(en)
|
1979-04-10 |
1981-08-25 |
Richardson-Merrell Inc. |
1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
|
US4254130A
(en)
|
1979-04-10 |
1981-03-03 |
Richardson-Merrell Inc. |
Piperidine derivatives
|
NZ193935A
(en)
|
1979-06-18 |
1985-05-31 |
Richardson Merrell Inc |
4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
|
IL61501A
(en)
|
1979-11-26 |
1984-06-29 |
Sterling Drug Inc |
5-(pyridinyl)-2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them
|
US4300557A
(en)
|
1980-01-07 |
1981-11-17 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method for treating intraocular malignancies
|
US4512978A
(en)
*
|
1980-01-24 |
1985-04-23 |
Inwood Louis R |
Dermatological composition useful in the treatment of psoriasis
|
DE3009034A1
(de)
|
1980-03-08 |
1981-09-24 |
Basf Ag, 6700 Ludwigshafen |
10-substituierte 5-cyanmethylendibenzo (a,d) -cycloheptne
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
US4394508A
(en)
|
1980-06-07 |
1983-07-19 |
Bristol-Myers Company |
Chemical compounds
|
US4316885A
(en)
|
1980-08-25 |
1982-02-23 |
Ayerst, Mckenna And Harrison, Inc. |
Acyl derivatives of rapamycin
|
US4384996A
(en)
|
1981-01-09 |
1983-05-24 |
Sandoz Ltd. |
Novel cyclosporins
|
US4513002A
(en)
|
1981-01-16 |
1985-04-23 |
Hoffmann-La Roche Inc. |
Cycloheptene derivatives
|
US4510309A
(en)
|
1981-03-03 |
1985-04-09 |
Bristol-Myers Company |
Histamine H2 -antagonists
|
US4877805A
(en)
|
1985-07-26 |
1989-10-31 |
Kligman Albert M |
Methods for treatment of sundamaged human skin with retinoids
|
JPS5851853A
(ja)
|
1981-09-18 |
1983-03-26 |
Kyowa Hakko Kogyo Co Ltd |
リン脂質混合物の処理法
|
PT75625B
(en)
|
1981-10-08 |
1985-12-09 |
Merck & Co Inc |
Process for preparing biosoluble ocular insert
|
US4517199A
(en)
|
1981-11-20 |
1985-05-14 |
Alcon Laboratories, Inc. |
Method for lowering intraocular pressure using phenylimino-imidazoles
|
US4486432A
(en)
|
1982-09-30 |
1984-12-04 |
Eli Lilly And Company |
Quinoxalinedione leukotriene release inhibitors
|
DE3241102A1
(de)
|
1982-11-06 |
1984-05-10 |
A. Nattermann & Cie GmbH, 5000 Köln |
Imidazolylalkylthienyl-tetrahydropyridazine und verfahren zu ihrer herstellung
|
FR2541680B1
(fr)
|
1983-02-24 |
1985-06-14 |
Rhone Poulenc Sante |
Nouveaux derives de l'amino-5 dithiole-1,2 one-3, leur preparation et les compositions medicinales qui les contiennent
|
JPS59167590A
(ja)
|
1983-03-14 |
1984-09-21 |
Kyorin Pharmaceut Co Ltd |
ピラゾロ〔1,5−a〕ピリジン誘導体、その製法及びそれを含有する治療剤
|
US4440933A
(en)
|
1983-03-16 |
1984-04-03 |
Bristol-Myers Company |
Process for preparing 1,2,5-thiadiazoles
|
US4569935A
(en)
*
|
1983-03-17 |
1986-02-11 |
University Of Tennessee Research Corp. |
Topical treatment of psoriasis with imidazole antibiotics
|
US5169637A
(en)
|
1983-03-24 |
1992-12-08 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles
|
CA1237671A
(fr)
|
1983-08-01 |
1988-06-07 |
Michael W. Fountain |
Augmentation de l'activite pharmaceutique
|
GB8321157D0
(en)
|
1983-08-05 |
1983-09-07 |
Fordonal Sa |
Piperidine derivatives
|
GB8400863D0
(en)
|
1984-01-13 |
1984-02-15 |
Smith Kline French Lab |
Chemical compounds
|
US4894366A
(en)
|
1984-12-03 |
1990-01-16 |
Fujisawa Pharmaceutical Company, Ltd. |
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
|
US5639724A
(en)
|
1984-07-24 |
1997-06-17 |
Sandoz Ltd. |
Cyclosporin galenic forms
|
US4582822A
(en)
|
1984-10-09 |
1986-04-15 |
Eli Lilly And Company |
Antibiotic A80190, pharmaceutical compositions containing same and method of use
|
US5254562A
(en)
|
1984-12-03 |
1993-10-19 |
Fujisawa Pharmaceutical Company, Ltd. |
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
|
GB8509276D0
(en)
|
1985-04-11 |
1985-05-15 |
Smith Kline French Lab |
Pyridine derivatives
|
US4824863A
(en)
|
1985-05-28 |
1989-04-25 |
Eli Lilly And Company |
Antibiotic A80438
|
US5409704A
(en)
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
US4975282A
(en)
|
1985-06-26 |
1990-12-04 |
The Liposome Company, Inc. |
Multilamellar liposomes having improved trapping efficiencies
|
JPS625963A
(ja)
|
1985-07-02 |
1987-01-12 |
Mitsui Toatsu Chem Inc |
イソキノリン誘導体
|
US4655074A
(en)
|
1985-08-12 |
1987-04-07 |
The Babcock & Wilcox Company |
Self-zeroing pressure transmitter with automatic pressure manifold
|
FR2588189B1
(fr)
|
1985-10-03 |
1988-12-02 |
Merck Sharp & Dohme |
Composition pharmaceutique de type a transition de phase liquide-gel
|
ZW20586A1
(en)
|
1985-10-17 |
1988-05-25 |
Smith Kline French Lab |
Chemical compounds
|
US4650803A
(en)
|
1985-12-06 |
1987-03-17 |
University Of Kansas |
Prodrugs of rapamycin
|
US5023087A
(en)
|
1986-02-10 |
1991-06-11 |
Liposome Technology, Inc. |
Efficient method for preparation of prolonged release liposome-based drug delivery system
|
GB8607684D0
(en)
|
1986-03-27 |
1986-04-30 |
Ici America Inc |
Thiazepine compounds
|
US4742175A
(en)
|
1986-05-07 |
1988-05-03 |
Merrell Dow Pharmaceuticals Inc. |
Preparation of polymorphically pure terfenadine
|
IE60901B1
(en)
|
1986-08-21 |
1994-08-24 |
Vestar Inc |
Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
|
US5049388A
(en)
|
1986-11-06 |
1991-09-17 |
Research Development Foundation |
Small particle aerosol liposome and liposome-drug combinations for medical use
|
NZ222843A
(en)
|
1986-12-22 |
1989-10-27 |
Ortho Pharma Corp |
Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
|
US4956388A
(en)
|
1986-12-22 |
1990-09-11 |
Eli Lilly And Company |
3-aryloxy-3-substituted propanamines
|
US5096906A
(en)
|
1986-12-31 |
1992-03-17 |
University Of Virginia Alumni Patents Foundation |
Method of inhibiting the activity of leukocyte derived cytokines
|
US4965271A
(en)
|
1986-12-31 |
1990-10-23 |
Hoechst Roussel Pharmaceuticals, Inc. |
Method of inhibiting the activity of leukocyte derived cytokines
|
US5272153A
(en)
|
1986-12-31 |
1993-12-21 |
Hoechst-Roussel Pharmaceuticals, Inc. |
Method of inhibiting the activity of leukocyte derived cytokines
|
US5032582A
(en)
|
1987-02-27 |
1991-07-16 |
Liposome Technology, Inc. |
Method for treating fungal infections with amphotericin B/cholesterol sulfate composition
|
US4798823A
(en)
|
1987-06-03 |
1989-01-17 |
Merck & Co., Inc. |
New cyclosporin analogs with modified "C-9 amino acids"
|
JP2577049B2
(ja)
|
1987-06-04 |
1997-01-29 |
三共株式会社 |
シクロスポリン製剤
|
AU614965B2
(en)
|
1987-06-06 |
1991-09-19 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Thiadiazinones
|
US4925849A
(en)
|
1987-06-15 |
1990-05-15 |
Fujisawa Pharmaceutical Company, Ltd. |
Pharmaceutically useful pyrazolopyridines
|
GB2206880B
(en)
|
1987-07-16 |
1991-04-24 |
Farmos Oy |
Optical isomers of an imidazole derivative
|
US5227467A
(en)
|
1987-08-03 |
1993-07-13 |
Merck & Co., Inc. |
Immunosuppressive fluorinated cyclosporin analogs
|
US4839342A
(en)
*
|
1987-09-03 |
1989-06-13 |
University Of Georgia Research Foundation, Inc. |
Method of increasing tear production by topical administration of cyclosporin
|
EP0391909B1
(fr)
*
|
1987-09-03 |
1994-08-17 |
The University Of Georgia Research Foundation, Inc. |
Composition de cyclosporine oculaire
|
US4833138A
(en)
|
1987-10-23 |
1989-05-23 |
Washington University |
Phenothiazinealkaneamines for treatment of neurotoxic injury
|
EP0326307B1
(fr)
|
1988-01-23 |
1994-08-17 |
Kyowa Hakko Kogyo Co., Ltd. |
Dérivés de pyridazinone et préparations pharmaceutiques les contenant
|
US5188826A
(en)
|
1988-02-08 |
1993-02-23 |
Insite Vision Incorporated |
Topical ophthalmic suspensions
|
JP2717687B2
(ja)
|
1988-02-13 |
1998-02-18 |
日本曹達株式会社 |
ピリダジノン誘導体及びその製造方法
|
US5238959A
(en)
|
1988-04-08 |
1993-08-24 |
Eli Lilly And Company |
3-phenyloxy-3-phenyl propanamines
|
US5314875A
(en)
|
1988-05-02 |
1994-05-24 |
Eli Lilly And Company |
Method for treating swine dysentery with the derivatives of the antibiotic A82810
|
US4994213A
(en)
|
1988-05-17 |
1991-02-19 |
Liposome Technology, Inc. |
Method of preparing lipid structures
|
KR0148748B1
(ko)
|
1988-09-16 |
1998-08-17 |
장 크라메르, 한스 루돌프 하우스 |
사이클로스포린을 함유하는 약학조성물
|
US5342625A
(en)
|
1988-09-16 |
1994-08-30 |
Sandoz Ltd. |
Pharmaceutical compositions comprising cyclosporins
|
US6007840A
(en)
|
1988-09-16 |
1999-12-28 |
Novartis Ag |
Pharmaceutical compositions comprising cyclosporins
|
US4908372A
(en)
|
1988-10-13 |
1990-03-13 |
Merrell Dow Pharmaceuticals Inc. |
Antihistaminic piperidinyl benzimidazoles
|
GB8827820D0
(en)
|
1988-11-29 |
1988-12-29 |
Janssen Pharmaceutica Nv |
(1h-azol-1-ylmethyl)substituted quinoline derivatives
|
IL92351A
(en)
|
1988-11-29 |
1994-02-27 |
Allergan Inc Irvine |
Optimal aqueous solutions containing stabilized chlorine acid and inorganic salt
|
US5098443A
(en)
|
1989-03-23 |
1992-03-24 |
University Of Miami |
Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
|
US5281591A
(en)
|
1989-05-22 |
1994-01-25 |
Allergan, Inc. |
Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
|
US5021410A
(en)
|
1989-05-22 |
1991-06-04 |
Allergan, Inc. |
Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
|
US5180721A
(en)
|
1989-05-22 |
1993-01-19 |
Allergan, Inc. |
Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
|
NZ234186A
(en)
|
1989-07-07 |
1991-10-25 |
Janssen Pharmaceutica Nv |
Imidazo quinazolin-one derivatives and pharmaceutical compositions
|
US5284826A
(en)
|
1989-07-24 |
1994-02-08 |
Sandoz Ltd. |
0-hydroxyethyl and acyloxyethyl derivatives of [ser]8 cyclosporins
|
US5194266A
(en)
|
1989-08-08 |
1993-03-16 |
Liposome Technology, Inc. |
Amphotericin B/cholesterol sulfate composition and method
|
US5231096A
(en)
|
1989-10-12 |
1993-07-27 |
Allergan, Inc. |
Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
|
US5112822A
(en)
|
1989-10-12 |
1992-05-12 |
Allergan, Inc. |
(2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same
|
US5077292A
(en)
|
1989-10-12 |
1991-12-31 |
Allergan, Inc. |
(2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same
|
US5326763A
(en)
|
1989-10-12 |
1994-07-05 |
Allergan, Inc. |
Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
|
US5198442A
(en)
|
1989-10-12 |
1993-03-30 |
Allergan, Inc. |
(2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same
|
US5204347A
(en)
|
1989-10-12 |
1993-04-20 |
Allergan, Inc. |
Methods for using (2-imidazolin-2-ylamino) tetrahydroquinoxalines
|
US5356633A
(en)
|
1989-10-20 |
1994-10-18 |
Liposome Technology, Inc. |
Method of treatment of inflamed tissues
|
US5208228A
(en)
|
1989-11-13 |
1993-05-04 |
Merck & Co., Inc. |
Aminomacrolides and derivatives having immunosuppressive activity
|
US5215991A
(en)
|
1990-01-26 |
1993-06-01 |
Allergan, Inc. |
Combination of selective alpha-adrenergic agonists and Na+ /H+ ex
|
US5237072A
(en)
|
1990-02-06 |
1993-08-17 |
Allergan, Inc. |
Method for producing amino-2-imidazoline derivatives
|
US5130441A
(en)
|
1990-02-06 |
1992-07-14 |
Allergan, Inc. |
Method for producing amino-2-imidazoline derivatives
|
US5122511A
(en)
|
1990-02-27 |
1992-06-16 |
Merck & Co., Inc. |
Immunosuppressive cyclosporin analogs with modified amino acids at position-8
|
US4963561A
(en)
|
1990-02-28 |
1990-10-16 |
Sterling Drug Inc. |
Imidazopyridines, their preparation and use
|
US5252595A
(en)
|
1990-02-28 |
1993-10-12 |
Allergan, Inc. |
Method for reducing or maintaining intraocular pressure in the mammalian eye by administering pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenylamino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines
|
US5124455A
(en)
|
1990-08-08 |
1992-06-23 |
American Home Products Corporation |
Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
|
US5091528A
(en)
|
1990-09-12 |
1992-02-25 |
Allergan, Inc. |
6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
|
PT98990A
(pt)
|
1990-09-19 |
1992-08-31 |
American Home Prod |
Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
|
US5143918A
(en)
|
1990-10-11 |
1992-09-01 |
Merck & Co., Inc. |
Halomacrolides and derivatives having immunosuppressive activity
|
DE4034218A1
(de)
|
1990-10-27 |
1992-04-30 |
Merck Patent Gmbh |
Verfahren zur herstellung von carebastin
|
US5141931A
(en)
|
1991-01-03 |
1992-08-25 |
Sterling Winthrop Inc. |
5-Quinolinylpyridinones, cardiotonic compositions and methods
|
US5378475A
(en)
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
US5100883A
(en)
|
1991-04-08 |
1992-03-31 |
American Home Products Corporation |
Fluorinated esters of rapamycin
|
US5118678A
(en)
|
1991-04-17 |
1992-06-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
ATE139439T1
(de)
|
1991-04-19 |
1996-07-15 |
Nexstar Pharmaceuticals Inc |
Pharmazeutische formulierung und pharmazeutisches verfahren
|
US5162334A
(en)
|
1991-05-13 |
1992-11-10 |
Merck & Co., Inc. |
Amino O-alkyl, O-alkenyl and O-alkynlmacrolides having immunosuppressive activity
|
US5250678A
(en)
|
1991-05-13 |
1993-10-05 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
|
US5262533A
(en)
|
1991-05-13 |
1993-11-16 |
Merck & Co., Inc. |
Amino O-aryl macrolides having immunosuppressive activity
|
US5120725A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Bicyclic rapamycins
|
US5120727A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Rapamycin dimers
|
IL102236A0
(en)
|
1991-06-27 |
1993-01-14 |
Ltt Inst Co Ltd |
Topical preparations containing cyclosporin
|
US5169851A
(en)
|
1991-08-07 |
1992-12-08 |
American Home Products Corporation |
Rapamycin analog as immunosuppressants and antifungals
|
US5202332A
(en)
|
1991-08-07 |
1993-04-13 |
American Home Products Corporation |
Rapamycin analog as immunosuppressant
|
US5512575A
(en)
|
1991-08-15 |
1996-04-30 |
Zeneca Limited |
Methanoanthraceneyl methyl piperidinyl compounds
|
GB9216297D0
(en)
|
1991-08-15 |
1992-09-16 |
Ici Plc |
Therapeutic agents
|
GB9216298D0
(en)
|
1991-08-15 |
1992-09-16 |
Ici Plc |
Piperidine derivatives
|
US5189042A
(en)
|
1991-08-22 |
1993-02-23 |
Merck & Co. Inc. |
Fluoromacrolides having immunosuppressive activity
|
US5208241A
(en)
|
1991-09-09 |
1993-05-04 |
Merck & Co., Inc. |
N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
|
US5151413A
(en)
|
1991-11-06 |
1992-09-29 |
American Home Products Corporation |
Rapamycin acetals as immunosuppressant and antifungal agents
|
US5770592A
(en)
|
1991-11-22 |
1998-06-23 |
Alcon Laboratories, Inc. |
Prevention and treatment of ocular neovascularization using angiostatic steroids
|
US5278150A
(en)
|
1992-04-24 |
1994-01-11 |
Whitby Research, Inc. |
2-hydrazoadenosines and their utility for the treatmeat of vascular conditions
|
DK0642332T3
(da)
*
|
1992-05-13 |
1997-06-16 |
Sandoz Ltd |
Ophthalmiske præparater indeholdende cyclosporin
|
US5284840A
(en)
|
1992-06-12 |
1994-02-08 |
Merck & Co., Inc. |
Alkylidene macrolides having immunosuppressive activity
|
CA2141572C
(fr)
|
1992-08-03 |
2001-02-06 |
James W. Young |
Metabolites de terfenadine et leurs isomeres optiquement purs pour le traitement des allergies
|
GR1002207B
(en)
|
1992-08-06 |
1996-03-27 |
Johnson & Johnson Consumer |
Skin care compositions containing imidazoles.
|
US5258389A
(en)
|
1992-11-09 |
1993-11-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
|
US5552155A
(en)
|
1992-12-04 |
1996-09-03 |
The Liposome Company, Inc. |
Fusogenic lipsomes and methods for making and using same
|
MY113268A
(en)
|
1992-12-29 |
2002-01-31 |
Insite Vision Incorporated |
Plasticized bioerodible controlled delivery system
|
US5504091A
(en)
|
1993-04-23 |
1996-04-02 |
American Home Products Corporation |
Biotin esters of rapamycin
|
GB9311920D0
(en)
|
1993-06-09 |
1993-07-28 |
Pfizer Ltd |
Therapeutic agents
|
EP1369409B1
(fr)
|
1993-06-24 |
2006-04-05 |
AMR Technology, Inc. |
Procédé de préparation de composés utiles en tant qu'intermédiaires
|
US5965595A
(en)
|
1993-07-01 |
1999-10-12 |
The Procter & Gamble Company |
2-Imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists
|
WO1995007267A1
(fr)
|
1993-09-10 |
1995-03-16 |
Eisai Co., Ltd. |
Compose de quinazoline
|
EP0723447B1
(fr)
|
1993-10-13 |
2002-12-11 |
Allergan, Inc. |
Utilisation de derives de la quinoxaline (2 - imidazolin - 2 - ylamino)
|
US6323204B1
(en)
|
1993-10-13 |
2001-11-27 |
Allergan |
Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
|
US5580892A
(en)
|
1993-10-22 |
1996-12-03 |
Allergan |
Method for using 2-(2-alkylphenylamino)-oxazolines as adrenergic agents
|
US6022852A
(en)
|
1993-10-22 |
2000-02-08 |
Hexal Ag |
Pharmaceutical composition containing cyclosporin A
|
KR100327264B1
(ko)
|
1993-10-29 |
2002-07-02 |
요시히로 미와 |
인돌유도체,그의염및이를함유하는심질환치료제
|
US5574173A
(en)
|
1993-12-06 |
1996-11-12 |
Schering Corporation |
Tricyclic derivatives, compositions and methods of use
|
US5464840A
(en)
|
1993-12-06 |
1995-11-07 |
Schering Corporation |
Tricyclic derivatives, compositions and methods of use
|
US6117871A
(en)
|
1993-12-17 |
2000-09-12 |
The Procter & Gamble Company |
6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists
|
US5578607A
(en)
|
1993-12-17 |
1996-11-26 |
The Procter & Gamble Company |
6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
|
HU217841B
(hu)
|
1993-12-17 |
2000-04-28 |
The Procter & Gamble Co. |
6-[(2-Imidazolidinilidén)-amino]-kinolin-származékok és ezeket tartalmazó gyógyszerkészítmények
|
US5478858A
(en)
|
1993-12-17 |
1995-12-26 |
The Procter & Gamble Company |
5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
|
PT735877E
(pt)
|
1993-12-17 |
2000-12-29 |
Procter & Gamble |
Compostos de 6-(2-imidazolinilamino)quinoxalina uteis como agonistas do receptor alfa-2 adrenergico
|
US5576437A
(en)
|
1993-12-17 |
1996-11-19 |
The Procter & Gamble Company |
7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
|
GB9514465D0
(en)
|
1995-07-14 |
1995-09-13 |
Glaxo Lab Sa |
Chemical compounds
|
GB9401090D0
(en)
|
1994-01-21 |
1994-03-16 |
Glaxo Lab Sa |
Chemical compounds
|
ES2103151T3
(es)
|
1994-02-08 |
1997-08-16 |
Alcon Lab Inc |
Nuevos procedimientos para la preparacion de derivados de clonidina.
|
CH687062A5
(de)
|
1994-02-14 |
1996-09-13 |
Cerbios Pharma Sa |
Konzentrierte Injektionsloesung von Alkalimetallsalzen von reduzierten Folaten.
|
US5422116A
(en)
|
1994-02-18 |
1995-06-06 |
Ciba-Geigy Corporation |
Liquid ophthalmic sustained release delivery system
|
US5773021A
(en)
|
1994-03-14 |
1998-06-30 |
Vetoquinol S.A. |
Bioadhesive ophthalmic insert
|
US5466233A
(en)
|
1994-04-25 |
1995-11-14 |
Escalon Ophthalmics, Inc. |
Tack for intraocular drug delivery and method for inserting and removing same
|
US5474979A
(en)
|
1994-05-17 |
1995-12-12 |
Allergan, Inc. |
Nonirritating emulsions for sensitive tissue
|
IL114193A
(en)
|
1994-06-20 |
2000-02-29 |
Teva Pharma |
Ophthalmic pharmaceutical compositions based on sodium alginate
|
US5877180A
(en)
|
1994-07-11 |
1999-03-02 |
University Of Virginia Patent Foundation |
Method for treating inflammatory diseases with A2a adenosine receptor agonists
|
EP0775134A4
(fr)
|
1994-08-04 |
1997-08-13 |
Synaptic Pharma Corp |
Nouveaux derives de benzimidazole
|
NZ290952A
(en)
|
1994-08-09 |
1998-05-27 |
Eisai Co Ltd |
Phthalazine derivatives optionally substituted in position-1 by (generally benzyl) amino groups
|
US5693648A
(en)
|
1994-09-30 |
1997-12-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
|
US5545504A
(en)
|
1994-10-03 |
1996-08-13 |
Xerox Corporation |
Ink jettable toner compositions and processes for making and using
|
US6294563B1
(en)
|
1994-10-27 |
2001-09-25 |
Allergan Sales, Inc. |
Combinations of prostaglandins and brimonidine or derivatives thereof
|
AU3855995A
(en)
|
1994-11-11 |
1996-06-06 |
Nippon Soda Co., Ltd. |
Optically active compound
|
GB9423910D0
(en)
|
1994-11-26 |
1995-01-11 |
Pfizer Ltd |
Therapeutic agents
|
US5725493A
(en)
|
1994-12-12 |
1998-03-10 |
Avery; Robert Logan |
Intravitreal medicine delivery
|
US5693646A
(en)
|
1994-12-22 |
1997-12-02 |
Ligand Pharmaceuticals Incorporated |
Steroid receptor modulator compounds and methods
|
US5698560A
(en)
|
1995-03-01 |
1997-12-16 |
Kyowa Hakko Kogyo Co., Ltd. |
Imidazoquinazoline derivatives
|
DE19518082A1
(de)
|
1995-05-17 |
1996-11-21 |
Merck Patent Gmbh |
4(-Arylaminomethylen)-2,4-dihydropyrazol-3-one
|
US6369116B1
(en)
*
|
1995-06-02 |
2002-04-09 |
Oculex Pharmaceuticals, Inc. |
Composition and method for treating glaucoma
|
US5914342A
(en)
|
1995-06-07 |
1999-06-22 |
The Procter & Gamble Company |
2-imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists
|
AU5938996A
(en)
|
1995-06-07 |
1996-12-30 |
Nexstar Pharmaceuticals, Inc. |
Method for encapsulating pharmaceutical materials
|
US5856329A
(en)
|
1995-06-28 |
1999-01-05 |
Allergan |
Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
|
US6194415B1
(en)
|
1995-06-28 |
2001-02-27 |
Allergan Sales, Inc. |
Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury
|
US5916900A
(en)
|
1995-06-29 |
1999-06-29 |
The Procter & Gamble Company |
7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
|
US5804587A
(en)
|
1995-06-29 |
1998-09-08 |
The Procter & Gamble Company |
6-(2-imidazolinylamino) quinolines useful as alpha-2 adrenoceptor agonists
|
GB9514464D0
(en)
|
1995-07-14 |
1995-09-13 |
Glaxo Lab Sa |
Medicaments
|
US5773019A
(en)
|
1995-09-27 |
1998-06-30 |
The University Of Kentucky Research Foundation |
Implantable controlled release device to deliver drugs directly to an internal portion of the body
|
DE19537012A1
(de)
|
1995-10-04 |
1997-04-10 |
Dietl Hans |
Cyclosporin(e) enhaltende pharmazeutische Zubereitung zur oralen Applikation und Verfahren zu ihrer Herstellung
|
US6201124B1
(en)
|
1995-12-21 |
2001-03-13 |
Albany Molecular Research, Inc. |
Process for production of piperidine derivatives
|
US6153754A
(en)
|
1995-12-21 |
2000-11-28 |
Albany Molecular Research, Inc. |
Process for production of piperidine derivatives
|
TR199802282T2
(xx)
|
1996-05-10 |
1999-03-22 |
Icos Corporation |
Karbolin t�revleri.
|
US5709797A
(en)
|
1996-06-05 |
1998-01-20 |
Poli Industria Chimica S.P.A. |
Method of isolating cyclosporins
|
US5789416B1
(en)
|
1996-08-27 |
1999-10-05 |
Cv Therapeutics Inc |
N6 mono heterocyclic substituted adenosine derivatives
|
JP2001502307A
(ja)
|
1996-10-04 |
2001-02-20 |
ノボ ノルディスク アクティーゼルスカブ |
1,4―ジ置換ピペラジン
|
DE19644228A1
(de)
|
1996-10-24 |
1998-04-30 |
Merck Patent Gmbh |
Thienopyrimidine
|
US6306877B1
(en)
|
1999-08-09 |
2001-10-23 |
The Procter & Gamble Co. |
Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
|
JP2001506600A
(ja)
|
1996-11-25 |
2001-05-22 |
ザ プロクター アンド ギャンブル カンパニー |
α―2アドレナリン受容体作動薬として有用なグアニジニル複素環式化合物
|
CA2272683A1
(fr)
|
1996-11-25 |
1998-06-04 |
The Procter & Gamble Company |
Composes 2-imidazolinylaminobenzoxazole convenant comme agonistes de l'adrenorecepteur .alpha.-2
|
US6172095B1
(en)
|
1996-11-25 |
2001-01-09 |
The Procter & Gamble Company |
Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
|
CA2271841C
(fr)
|
1996-11-25 |
2003-07-08 |
The Procter & Gamble Company |
Composes de 2-imidazolinylaminoindole servant de recepteurs adrenergiques alpha-2
|
US5888493A
(en)
|
1996-12-05 |
1999-03-30 |
Sawaya; Assad S. |
Ophthalmic aqueous gel formulation and related methods
|
US5837713A
(en)
*
|
1997-02-26 |
1998-11-17 |
Mayo Foundation For Medical Education And Research |
Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids
|
US6495583B1
(en)
|
1997-03-25 |
2002-12-17 |
Synaptic Pharmaceutical Corporation |
Benzimidazole derivatives
|
EP0977756A1
(fr)
|
1997-04-25 |
2000-02-09 |
Pfizer Limited |
PYRAZOLOPYRIMIDINONES INHIBANT LA PHOSPHODIESTERASE D'ACIDE GUANOSINE-3'5'-MONOPHOSPHATE CYCLIQUE (cGMP PDE5) S'UTILISANT POUR TRAITER DES DYSFONCTIONS SEXUELLES
|
US6342507B1
(en)
|
1997-09-05 |
2002-01-29 |
Isotechnika, Inc. |
Deuterated rapamycin compounds, method and uses thereof
|
JP4261049B2
(ja)
|
1997-10-08 |
2009-04-30 |
アイソテクニカ インコーポレイテッド |
重水素化シクロスポリンアナログおよび免疫調節剤としてのそれらの使用
|
US6156753A
(en)
|
1997-10-28 |
2000-12-05 |
Vivus, Inc. |
Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
AU740758B2
(en)
|
1997-10-28 |
2001-11-15 |
Vivus, Inc. |
Treatment of female sexual dysfunction
|
SK7792000A3
(en)
|
1997-11-24 |
2001-01-18 |
Procter & Gamble |
5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as alpha-adrenoceptor agonists with improved metabolic stability
|
US6066740A
(en)
|
1997-11-25 |
2000-05-23 |
The Procter & Gamble Company |
Process for making 2-amino-2-imidazoline, guanidine and 2-amino-3,4,5,6-tetrahydropyrimidine derivatives
|
EA200000526A1
(ru)
|
1997-12-16 |
2000-12-25 |
Пфайзер Продактс Инк. |
Комбинация, эффективная для лечения импотенции
|
CO4980885A1
(es)
|
1997-12-29 |
2000-11-27 |
Ortho Mcneil Pharm Inc |
Compuestos de trifenilpropanamida utiles en el tratamiento de inflamaciones y metodos para preparar dicho compuesto
|
US5981607A
(en)
*
|
1998-01-20 |
1999-11-09 |
Allergan |
Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
US6380207B2
(en)
|
1998-02-13 |
2002-04-30 |
Abbott Laboratories |
Glucocortiocoid-selective antiinflammatory agents
|
EP1056454B1
(fr)
|
1998-02-23 |
2003-05-02 |
Fujisawa Pharmaceutical Co., Ltd. |
Utilisation de macrolides pour le traitement du glaucome
|
TR200003130T2
(tr)
|
1998-04-28 |
2001-01-22 |
Arzneimittelwerk Dresden Gmbh |
Yeni hidroksiindoller, bunların fosfodiesteraz 4 inhibitörleri olarak kullanımları ve hazırlanmaları için işlemler
|
US6235781B1
(en)
|
1998-07-14 |
2001-05-22 |
Alcon Laboratories, Inc. |
Prostaglandin product
|
US20040152664A1
(en)
*
|
1998-09-02 |
2004-08-05 |
Allergan, Inc. |
Prednisolone compositions
|
US6242442B1
(en)
|
1998-12-17 |
2001-06-05 |
Alcon Laboratories, Inc. |
Brinzolamide and brimonidine for treating ocular conditions
|
WO2000039099A1
(fr)
|
1998-12-24 |
2000-07-06 |
Fujisawa Pharmaceutical Co., Ltd. |
Derives de benzimidazole
|
US6232297B1
(en)
|
1999-02-01 |
2001-05-15 |
University Of Virginia Patent Foundation |
Methods and compositions for treating inflammatory response
|
US6254860B1
(en)
|
1999-04-13 |
2001-07-03 |
Allergan Sales, Inc. |
Ocular treatment using cyclosporin-A derivatives
|
US20010053780A1
(en)
|
1999-04-30 |
2001-12-20 |
Whitaker John S. |
Daily treatment for erectile dysfunction using a PDE5 inhibitor
|
EE05584B1
(et)
|
1999-04-30 |
2012-10-15 |
Pfizer Products Inc. |
Glkokortikoidretseptori modulaatorid
|
US6943166B1
(en)
|
1999-04-30 |
2005-09-13 |
Lilly Icos Llc. |
Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction
|
AU4558800A
(en)
|
1999-05-04 |
2000-11-17 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Synergistic combination comprising roflumilast and a pde-3 inhibitor
|
WO2000068230A1
(fr)
|
1999-05-05 |
2000-11-16 |
Darwin Discovery Limited |
Derives de 9-(1,2,3,4-tetrahydronapththalene-1-yle)-1,9-dihydropurine-6-un inhibiteurs de pde7
|
IT1313583B1
(it)
|
1999-07-30 |
2002-09-09 |
Chiesi Farma Spa |
Derivati 2-amminotetralinici per la terapia del glaucoma.
|
US6593480B2
(en)
|
1999-09-01 |
2003-07-15 |
Abbott Laboratories |
Glucocorticoid receptor antagonists for treatment of diabetes
|
US6331313B1
(en)
*
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
US7323496B2
(en)
|
1999-11-08 |
2008-01-29 |
Theracos, Inc. |
Compounds for treatment of inflammation, diabetes and related disorders
|
AU1590501A
(en)
|
1999-11-12 |
2001-06-06 |
Merck & Co., Inc. |
Aliphatic hydroxy substituted piperidyl diaryl pyrrole derivatives as antiprotozoal agents
|
AU781552B2
(en)
|
1999-11-12 |
2005-05-26 |
Merck Sharp & Dohme Corp. |
Diaryl piperidyl pyrrole derivatives as antiprotozoal agents
|
TWI227143B
(en)
|
1999-12-15 |
2005-02-01 |
Guo-Jiun Sung |
In situ gel formation for ophthalmic delivery by combining Pluronic/Carbopol medic composition and its preparing method
|
US6258833B1
(en)
|
1999-12-23 |
2001-07-10 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
US6372777B1
(en)
|
1999-12-23 |
2002-04-16 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
JP2003522165A
(ja)
|
2000-01-31 |
2003-07-22 |
ファイザー・プロダクツ・インク |
Pde4アイソザイムの阻害剤として有用なピリミジンカルボキサミド
|
EP1265861A2
(fr)
|
2000-03-16 |
2002-12-18 |
Inflazyme Pharmaceuticals, Ltd. |
Inhibiteurs benzyles de pde4
|
US6919337B2
(en)
|
2000-04-07 |
2005-07-19 |
Novartis, Ag |
8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
|
GB0008694D0
(en)
|
2000-04-07 |
2000-05-31 |
Novartis Ag |
Organic compounds
|
DK1142566T3
(da)
*
|
2000-04-07 |
2004-02-09 |
Medidom Lab |
Oftalmologiske formuleringer på basis af ciclosporin, hyaluronsyre og polysorbat
|
US7019136B2
(en)
|
2000-04-07 |
2006-03-28 |
Novartis, Ag |
8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
|
SK17052002A3
(sk)
|
2000-06-05 |
2003-12-02 |
Altana Pharma Ag |
Pyridazinónové zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie
|
BR0109317A
(pt)
|
2000-07-14 |
2003-06-17 |
Allergan Inc |
Composições contendo componentes agonistas alfa-2-adrenérgicos
|
BR0112461A
(pt)
|
2000-07-14 |
2003-07-22 |
Allergan Inc |
Composições que contém componentes terapeuticamente ativos tendo uma solubilidade aumentada
|
RU2275359C2
(ru)
|
2000-08-11 |
2006-04-27 |
Оно Фармасьютикал Ко., Лтд. |
Производные пиперидина и средство, содержащее производное пиперидина в качестве активного ингредиента
|
US6719750B2
(en)
|
2000-08-30 |
2004-04-13 |
The Johns Hopkins University |
Devices for intraocular drug delivery
|
DE10145910A1
(de)
|
2000-09-18 |
2002-06-20 |
Registrar University Of Delhi |
Ophtalmologische Formulierung mit verlangsamter Freisetzung und langer Verweildauer sowie Herstellungsverfahren hierfür
|
US6545057B2
(en)
|
2000-09-26 |
2003-04-08 |
The Brigham And Women's Hospital Inc. |
Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics
|
IL146057A
(en)
|
2000-10-27 |
2007-09-20 |
Pfizer Prod Inc |
A process for the preparation of modulators of a non-steroidal glucocorticoid receptor
|
TWI262920B
(en)
|
2000-10-27 |
2006-10-01 |
Elbion Ag |
New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
|
ATE327974T1
(de)
|
2000-10-28 |
2006-06-15 |
Pfizer Prod Inc |
Modulatoren des glucocorticoid-rezeptors
|
JP4107421B2
(ja)
|
2000-11-06 |
2008-06-25 |
リリー アイコス リミテッド ライアビリティ カンパニー |
Pde5阻害剤としてのインドール誘導体
|
WO2002038563A2
(fr)
|
2000-11-08 |
2002-05-16 |
Lilly Icos Llc |
Composes chimiques
|
BR0115364A
(pt)
|
2000-11-17 |
2003-09-23 |
Warner Lambert Co |
Tratamento de disfunção sexual
|
EA200300622A1
(ru)
|
2001-01-31 |
2003-12-25 |
Пфайзер Продактс Инк. |
Производные амидов тиазолил-, оксазолил, пирролил- и имидазолилкислот, полезные в качестве ингибиторов изоферментов pde4
|
BR0116845A
(pt)
|
2001-01-31 |
2004-02-25 |
Pfizer Prod Inc |
Derivados éter úteis como inibidores de isozimas pde4
|
BR0116852A
(pt)
|
2001-01-31 |
2004-02-25 |
Pfizer Prod Inc |
Derivados biarilados de nicotinamida úteis como inibidores de isozimas pde4
|
US7250518B2
(en)
|
2001-01-31 |
2007-07-31 |
Pfizer Inc. |
Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
|
US6583180B2
(en)
|
2001-02-14 |
2003-06-24 |
Abbott Laboratories |
Glucocorticoid receptor modulators
|
NZ527424A
(en)
|
2001-02-15 |
2005-02-25 |
Altana Pharma Ag |
Phthalayinone-piperidino-derivatives as PDE4 inhibitors
|
US6617357B2
(en)
|
2001-03-06 |
2003-09-09 |
Smithkline Beecham Corporation |
Compounds and their use as PDE inhibitors
|
US6713081B2
(en)
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
AP1699A
(en)
|
2001-03-21 |
2006-12-26 |
Warner Lambert Co |
New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
|
US6958328B2
(en)
|
2001-04-18 |
2005-10-25 |
Ortho-Mcneil Pharmaceutical, Inc |
Arylindenopyridines and related therapeutic and prophylactic methods
|
MXPA03010679A
(es)
|
2001-05-23 |
2004-03-02 |
Tanabe Seiyaku Co |
Una composicion para acelerar la cicatrizacion de fractura osea.
|
US20040180900A1
(en)
|
2001-05-23 |
2004-09-16 |
Masaharu Takigawa |
Therapeutic composition for repairing chondropathy
|
US6992192B2
(en)
|
2001-06-05 |
2006-01-31 |
Lilly Icos Llc. |
Carboline derivatives as PDE5 inhibitors
|
RU2285002C2
(ru)
|
2001-06-15 |
2006-10-10 |
Астеллас Фарма Инк. |
Производное пиридина и фармацевтическая композиция на его основе
|
PE20030008A1
(es)
|
2001-06-19 |
2003-01-22 |
Bristol Myers Squibb Co |
Inhibidores duales de pde 7 y pde 4
|
HUP0402352A2
(hu)
|
2001-06-19 |
2005-02-28 |
Bristol-Myers Squibb Co. |
Foszfodiészteráz (PDE) 7 inhibitorként alkalmazható pirimidinszármazékok és ezeket tartalmazó gyógyszerkészítmények
|
GB0115181D0
(en)
*
|
2001-06-20 |
2001-08-15 |
Glaxo Group Ltd |
Novel use
|
WO2003000691A1
(fr)
|
2001-06-21 |
2003-01-03 |
Lilly Icos Llc |
Derives de carboline en tant qu'inhibiteurs de pdev
|
DE60204463T2
(de)
|
2001-06-27 |
2006-05-18 |
Merck Frosst Canada & Co, Kirkland |
Substituierte 8-Arylchinoline als PDE4-Hemmer
|
US6872705B2
(en)
|
2001-07-13 |
2005-03-29 |
Allergan, Inc. |
Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
|
JP2004536614A
(ja)
|
2001-08-01 |
2004-12-09 |
ユニバーシティ オブ ユタ |
Pde3環状ヌクレオチド・ホスホジエステラーゼのアイソフォーム選択的な阻害剤および活性化剤
|
DE10141212A1
(de)
|
2001-08-22 |
2003-03-06 |
Bayer Ag |
Neue 4-Aminofuropyrimidine und ihre Verwendung
|
US20030176316A1
(en)
|
2001-08-24 |
2003-09-18 |
Whitehead Clark M. |
Methods for treatment of rheumatoid arthritis
|
US6582422B2
(en)
|
2001-10-03 |
2003-06-24 |
Bausch & Lomb Incorporated |
Ophthalmic delivery device
|
US6809077B2
(en)
|
2001-10-12 |
2004-10-26 |
Enanta Pharmaceuticals, Inc. |
Cyclosporin analogs for the treatment of autoimmune diseases
|
EP1304321A3
(fr)
|
2001-10-17 |
2003-07-30 |
Samsung Electronics Co., Ltd. |
Procédé de préparation de 3-hydroxyesters à partir de dérives d'époxyde
|
WO2003037349A1
(fr)
*
|
2001-10-31 |
2003-05-08 |
Merck Patent Gmbh |
Inhibiteurs de la phosphodiesterase de type 4 et leurs utilisations
|
FR2832711B1
(fr)
|
2001-11-26 |
2004-01-30 |
Warner Lambert Co |
Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
|
CA2473886C
(fr)
|
2002-01-22 |
2012-08-21 |
The Regents Of The University Of California |
Ligands non steroidiens pour le recepteur des corticoides, compositions et utilisations desdits ligands
|
CA2475377A1
(fr)
|
2002-02-07 |
2003-08-14 |
Pfizer Inc. |
Utilisation d'inhibiteurs pde5, tel que le sildenafil, dans le traitement du syndrome d'ovaire polykystique
|
RS70104A
(en)
|
2002-02-11 |
2007-02-05 |
Pfizer Limited, |
Nicotinamide derivatives useful as pde4 inhibitors
|
MXPA04008171A
(es)
|
2002-02-22 |
2004-11-26 |
Pharmacia Corp |
Formulacion oftalmica con sistema de goma.
|
TWI347845B
(en)
*
|
2002-03-06 |
2011-09-01 |
Nycomed Gmbh |
Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
|
US6962940B2
(en)
|
2002-03-20 |
2005-11-08 |
Celgene Corporation |
(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
|
EP1348433A1
(fr)
|
2002-03-28 |
2003-10-01 |
Warner-Lambert Company LLC |
Thiazol-2-yl-imines comme inhibiteurs de la PDE7
|
EP1348701A1
(fr)
|
2002-03-28 |
2003-10-01 |
Warner-Lambert Company LLC |
Thiazol-5-yl-amines 2,4-disubstituées comme inhibiteurs de la PDE7
|
US7084157B2
(en)
*
|
2002-05-17 |
2006-08-01 |
Rajeev Raut |
Ophthalmic pharmaceutical compositions and methods for treating ocular inflammation
|
JP2005533829A
(ja)
|
2002-07-10 |
2005-11-10 |
アラクノーバ・セラピューティックス・リミテッド |
機能性腸疾患の処置における4−(2−フルオロフェニル)−6−メチル−2−(1−ピペラジニル)チエノ[2,3−d]ピリミジン
|
JP4254263B2
(ja)
*
|
2002-08-22 |
2009-04-15 |
日産自動車株式会社 |
ガス流量測定装置及びガス流量測定方法
|
WO2004021987A2
(fr)
|
2002-09-06 |
2004-03-18 |
Merck & Co., Inc. |
Traitement de la polyarthrite rhumatoide par inhibition de pde4
|
CN1681510A
(zh)
|
2002-09-16 |
2005-10-12 |
爱尔康制造有限公司 |
Pde ⅳ抑制剂治疗血管生成的用途
|
US20040167199A1
(en)
|
2002-11-18 |
2004-08-26 |
Celgene Corporation |
Methods of using and compositions comprising (-)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
|
US6909002B2
(en)
|
2002-11-22 |
2005-06-21 |
Merck & Co., Inc. |
Method of preparing inhibitors of phosphodiesterase-4
|
CA2510296A1
(fr)
|
2002-12-20 |
2004-07-15 |
Control Delivery Systems, Inc. |
Compositions de steroides pour utilisation intraoculaire
|
EP1594522A1
(fr)
*
|
2003-02-10 |
2005-11-16 |
Novartis AG |
Combinaisons pharmaceutiques contenant des corticoides et des immunodepresseurs pour traiter des maladies resistant aux inhibiteurs de corticoides et/ou de la calcineurine
|
CA2518409A1
(fr)
|
2003-03-12 |
2004-09-23 |
John P. Mullally |
Composition et procede de traitement d'inflammations par reduction des proteines c-reactives
|
US20040186046A1
(en)
|
2003-03-17 |
2004-09-23 |
Pfizer Inc |
Treatment of type 1 diabetes with PDE5 inhibitors
|
WO2004087906A1
(fr)
|
2003-03-31 |
2004-10-14 |
Pfizer Products Inc. |
Structure cristalline de 3',5'-phosphodiesterase nucleotidique cyclique 1d(pde1b) et ses utilisations
|
AU2004226353A1
(en)
|
2003-04-01 |
2004-10-14 |
Laboratoires Serono Sa |
Inhibitors of phosphodiesterases in infertility
|
JP2006523719A
(ja)
|
2003-04-18 |
2006-10-19 |
メモリー・ファーマシューティカルズ・コーポレイション |
ホスホジエステラーゼ4抑制剤としてのピラゾール誘導体
|
DE10318611A1
(de)
|
2003-04-24 |
2004-11-11 |
Elbion Ag |
4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
|
DE10318610A1
(de)
|
2003-04-24 |
2004-11-11 |
Elbion Ag |
7-Azaindole und deren Verwendung als Therapeutika
|
EP1477166B1
(fr)
|
2003-04-28 |
2006-08-23 |
Biofrontera Bioscience GmbH |
Utilisation du rilusole combiné avec des excipients et des additifs pour le traitement de troubles caractérisés par une hyperprolifération de kératinocytes, notamment la névrodermite et le psoriasis
|
JP2007500219A
(ja)
|
2003-05-16 |
2007-01-11 |
アンビット バイオサイエンシス コーポレーション |
複素環化合物およびその使用法
|
US20050042177A1
(en)
|
2003-07-23 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel compositions of sildenafil free base
|
US20050192261A1
(en)
*
|
2003-09-15 |
2005-09-01 |
Jost-Price Edward R. |
Methods and reagents for the treatment of immunoinflammatory disorders
|
US20050059583A1
(en)
*
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods of providing therapeutic effects using cyclosporin components
|
US20050112199A1
(en)
|
2003-09-24 |
2005-05-26 |
Mahesh Padval |
Therapeutic regimens for administering drug combinations
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
MY141255A
(en)
|
2003-12-11 |
2010-03-31 |
Memory Pharm Corp |
Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
|
EP1720555A1
(fr)
*
|
2004-02-26 |
2006-11-15 |
Advanced Ocular Systems Limited |
Derives de tetracycline utilises dans le traitement de pathologies oculaires
|
CA2560528A1
(fr)
|
2004-03-22 |
2005-10-06 |
Myogen, Inc. |
Sulfoxyde de (s)-enoximone et son utilisation dans le traitement de maladies mediees par pde-iii
|
WO2005092333A1
(fr)
|
2004-03-22 |
2005-10-06 |
Myogen, Inc. |
(r)-enoximone sulfoxyde et son utilisation dans le traitement de maladies induites par pde-iii
|
MXPA06011244A
(es)
|
2004-03-29 |
2007-04-13 |
Inotek Pharmaceuticals Corp |
Compuestos de porfirina sustituida por piridilo, y metodos de uso de los mismos.
|
US20050234018A1
(en)
|
2004-04-15 |
2005-10-20 |
Allergan, Inc. |
Drug delivery to the back of the eye
|
WO2005107463A1
(fr)
|
2004-05-03 |
2005-11-17 |
University Of Virginia Patent Foundation |
Agonistes de recepteurs de l'adenosine a2a servant au traitement d'une nephropathie diabetique
|
US20050277584A1
(en)
|
2004-06-09 |
2005-12-15 |
Allergan, Inc. |
Pharmaceutical compositions comprising cyclosporins
|
ATE439123T1
(de)
|
2004-07-02 |
2009-08-15 |
Novagali Pharma Sa |
Verwendung von emulsionen zur intra- und periocularen injection
|
ES2319797T3
(es)
|
2004-07-05 |
2009-05-12 |
Astellas Pharma Inc. |
Derivados de pirazolopiridina.
|
US20080269239A1
(en)
*
|
2004-11-11 |
2008-10-30 |
Argenta Discovery Ltd. |
Pyrimidine Compounds as Histamine Modulators
|
US20060122152A1
(en)
*
|
2004-12-03 |
2006-06-08 |
Peyman Gholam A |
Heparin for the treatment of ocular pathologies
|
WO2006073786A2
(fr)
*
|
2004-12-30 |
2006-07-13 |
Bausch & Lomb Incorporated |
Compositions opthalmiques comprenant un steroide et une cyclosporine pour le traitement de l'oeil sec
|
EP2218442A1
(fr)
|
2005-11-09 |
2010-08-18 |
CombinatoRx, Inc. |
Procédés, compositions et kits pour le traitement des maladies ophthalmiques
|
EP2521721B1
(fr)
|
2009-12-30 |
2014-10-01 |
Shanghai Fochon Pharmaceutical Co. Ltd |
Dérivés de 3-(3-aminopipéridin-1-yl)-5-oxo-1,2,4-triazine à titre d'inhibiteurs de dipeptidyl peptidase iv (dpp-iv)
|